Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

Psychological Flexibility fostered with guided ACT therapy improves responsiveness to chronic pain treatment.
Prescription cough and cold medication containing opioids such as codeine and hydrocodone to be indicated only for those over age 18.
Patients with diagnosed intractable pain will now qualify for medical cannabis treatment in Illinois.
In an effort to reduce opioid misuse and deter abuse, CDC clarifies dosing thresholds listed in its 2016 Guidelines are not meant for addiction treatment.
GSK and NeuroMetrix collaborate on global efforts to expand wearable technology for chronic pain relief.
MyDx Cannabis Formula Trial for Pain Management Gets Under Way
Using a multidimensional approach to assessing pain, like the CAPA tool, will assure better pain care than relying on the numerical pain scale.
Technology designed for chronic pain care providers' practices to improve communication, documentation, and record-keeping.
The race to unravel the kappa opioid receptor to find adverse-free alternatives to chronic pain treatment is gaining traction.
Centrexion Therapeutics is dedicating $67 million to Phase 3 studies for relieving chronic knee pain due to osteoarthritis.
Significant time delays found among subgroup populations in first on-treatment for chronic pain associated with sickle cell disease pain
Spinal cord stimulators continue to grow as a treatment for chronic pain.
A brief self-assessment, the COMM-9, is effective as an opioid monitoring tool use with equal accuracy in the pain management setting.
There is a complex relationship between chronic pain, yet long-term health matters more than perceived lost pleasure to most smokers.
Patients with chronic low back pain participated in a spa and exercise therapy trial to determine the program's effect on pain scale and return to work.